Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. 1990

J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
Department of Dermatology, New York University School of Medicine, New York.

A total of 452 patients with dysplastic nevi (DN) were followed prospectively by repetitive, complete cutaneous examinations in order to determine the clinical features of early malignant melanomas (MM) arising in them. Sixteen patients (3.5%) developed 18 newly diagnosed MM during an average follow-up period of 27 months. Twelve of the 18 MM were in situ and all of the primary invasive MM diagnosed prospectively in this follow-up were less than 0.89 mm in Breslow thickness, implying an excellent prognosis. The principal clinical clue to the diagnosis of MM was change in a preexisting pigmented lesion. Total-body photographs were very useful in helping to identify the early MM in these patients.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004416 Dysplastic Nevus Syndrome Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed) B-K Mole Syndrome,Familial Atypical Multiple Mole-Melanoma,Nevus Syndrome, Dysplastic,Nevus, Dysplastic,Dysplastic Nevi,B K Mole Syndrome,Dysplastic Nevus,Familial Atypical Multiple Mole Melanoma,Nevi, Dysplastic,Syndrome, B-K Mole,Syndrome, Dysplastic Nevus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
January 1985, Human pathology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
January 1985, The American Journal of dermatopathology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
January 1972, Voprosy onkologii,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
April 1993, Journal of cutaneous pathology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
October 2002, Journal of cutaneous pathology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
August 2001, The American Journal of dermatopathology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
May 1984, Journal of the American Academy of Dermatology,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
October 2011, Melanoma research,
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
April 1987, Deutsche medizinische Wochenschrift (1946),
J K Rivers, and A W Kopf, and A F Vinokur, and D S Rigel, and R J Friedman, and E R Heilman, and M Levenstein
December 2012, Melanoma research,
Copied contents to your clipboard!